Trial intelligence / Profile preview

Sitagliptin Effect on GH-Mediated Vasodilation

NCT01701973Phase 4Completed

Sponsor
Vanderbilt University
Start
Jan 2013
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sitagliptin in obesity, prediabetes, sponsored by Vanderbilt University. Started Jan 2013; status: completed.

02

Drugs

sitagliptin
03

Conditions

obesityprediabetes

Beyond the preview

Go deeper on NCT01701973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01701973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call